CTCE 0324

Drug Profile

CTCE 0324

Alternative Names: CTCE-0324

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chemokine Therapeutics
  • Class Chemokines; Vascular disorder therapies
  • Mechanism of Action Angiogenesis inducing agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Peripheral vascular disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Peripheral-vascular-disorders in Canada (Parenteral, Injection)
  • 25 Jul 2006 Preclinical data from a media release have been added to the Vascular disorders pharmacodynamics section
  • 07 Mar 2006 Preclinical trials in Peripheral vascular disorders in Canada (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top